comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 08:53:17 - browse：36888

For all their potential to drive changes in health, wearables have struggled to gain a foothold in medicine. The dramatic changes during pregnancy are a fertile ground to test their potential, though — and new research shows how applying machine learning methods to streams of data from wearable devices could be used to understand the mystery of premature birth.

Machine learning researchers at Stanford University used a deep learning model to analyze wearable activity and sleep data from pregnant participants. No surprise: Their sleep typically got worse and their activity slowed down over the course of pregnancy. But some participants had data profiles that didn’t match their pregnancy stage — and it was those pregnancies, the researchers found, that were more likely to result in a preterm birth.

Preterm birth is the leading cause of death in children under five around the world, and in the United States, about 11% of all live births occur before 37 weeks of gestation — a number that’s been steadily increasing over the last decade. Black women are particularly at risk, being about 1.5 times as likely as white women to deliver prematurely.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： High breast density mammograms need follow

WSS

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Young boy dies in trial for Pfizer Duchenne gene therapy

Study: Black kids more likely to die after surgery than white kids

Medicare bonuses could stop drug shortages under Senate plan

Inaction leaves children at risk from dangerous chemotherapy drug

focus

comprehensive

hotspot

Apple is now the first public company to be valued at $3 trillion

What causes osteoarthritis? Researchers study link to brain protein

Apple is now the first public company to be valued at $3 trillion

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Medicare details structure of new drug price negotiation program

Head of FDA's diagnostics center, who led through Covid, retires

United colonoscopy coverage change 'may cost lives,' doctors say

Republican states more likely to report Covid vaccine side effects

Medical leaders decry Supreme Court decision on affirmative action

U.K. decision on ALS drug has neurologists, advocates up in arms

hotspot

Pancreatic cancer is often deadly, but new discoveries are raising hope

TikTok, Instagram influencers need more rules for drug ads

Researchers test human milk's ability to repair gut microbiome

High breast density mammograms need follow

Flu vaccine reformulation won't be easy, manufacturers warn

The inclusion problem at the heart of rehabilitation research

hotspot

focus

hotspot

hotspot